Submissions

GENERAL INFORMATION

DHR Proceedings is the first journal in the Rio Grande Valley, Texas dedicated to publish original research that focuses on clinical medicine as well as basic sciences. While DHR Proceedings is sponsored by DHR Health Institute for Research and Development, it welcomes submissions from authors worldwide that support the professional and educational needs of its readers. DHR Proceedings is currently an online only journal.

All inquiries regarding journal policy should be directed to the Editorial Office at (956) 362-2392, Monday through Friday from 8:00 AM to 5:00 PM Central time or by e-mail at [email protected].


MANUSCRIPT SUBMISSION

All manuscripts must be submitted electronically at www.dhrproceedings.org. You will be prompted to create an account, if you don’t have one yet.  Once the account is created, you will be able to submit your manuscript. If you are unsure about whether you have an account or have forgotten your password, enter your e-mail address into the "Password Help" section of the login screen. If an account has already been established, you will receive an e-mail with your account information. Please review all instructions before starting a new submission. Paper submissions cannot be accepted.

Submission Process: Once you have successfully logged in, click on "New Submission," follow the steps and instructions provided. An article must be submitted to one of the Journal’s sections: Editorial, Commentaries, Brief reports, Research Manuscripts, Case Studies, Review Articles, Healthcare Policy and economics, Medical Education, Laboratory Medicine. Please see below under Manuscript Categories for descriptions on each section. If you are interrupted during the submission process, your work will automatically be saved and you can return to it at a later time to finish the submission process. Please make sure all e-mail addresses are entered correctly.  Authors are required to recommend at least 2 preferred reviewers, and have the option of providing non-preferred reviewer names. DHR Proceedings reserves the right for selection of reviewers. The Editorial Office is automatically notified of the submission and sends an e-mail confirming the submission of the manuscript to the author(s).

DHR Proceedings highly recommends to always keep copies of submitted manuscripts, including figures and other supporting information. If an author does not receive confirmation of submission within 48 hours, he or she should contact the Editorial Office at (956) 326-2392. If notice has not been received, the manuscript has not been completely submitted.

Peer Review Process. This journal operates a single blind review process. The Editorial Board will initially review all contributions for suitability for the journal and section. This initial review is usually completed within 1 to 2 weeks of manuscript submission. Once the Editorial Board review is complete, manuscripts are either forwarded on to peer review or rejected. Before a manuscript is sent for peer review, it will be checked for plagiarism using a commercial program. Papers deemed suitable for peer review will be sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. If there is large discrepancy between the two reviewers, a third reviewer might be recruited to provide their assessment of the manuscript.  The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final.

Authorship

DHR Proceedings follows the International Committee of Medical Journal Editors (ICMJE) recommendations on authorship. According to the ICMJE, all authors should have participated sufficiently in the work to take public responsibility for the content, either all of the work or an important part of it. To take public responsibility, an authors must be able to defend the content (all or an important part) and conclusions of the article if publicly challenged. Sufficient participation means that substantial contributions have been made in each of the following areas:

1. Conception and design of the work; or acquisition, analysis, or interpretation of the data for the work; and
2. Drafting the work or revising it critically for important intellectual content; and
3. Approval of the version to be published; and

4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged. These authorship criteria are intended to reserve the status of authorship for those who deserve credit and can take responsibility for the work. The criteria are not intended for use as a means to disqualify colleagues from authorship who otherwise meet authorship criteria by denying them the opportunity to meet criterion #s 2 or 3. Therefore, all individuals who meet the first criterion should have the opportunity to participate in the review, drafting, and final approval of the manuscript. Disclosure of author’s role on the manuscript is required under the following categories: conceptualization, design, data acquisition, data analysis, data interpretation, manuscript writing, and critical review of manuscript. Each author’s contribution must be included before the acknowledgement’s section. For more information, please see www.icmje.org.

Each manuscript should have 1 author designated as the primary contact and corresponding author for all communications about the submission, and, if it is accepted for publication, the published article. The corresponding author assumes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that all the journal's administrative requirements are properly completed.

Requests for removal or addition of an author after manuscript submission should be explained in writing, with a signed statement of agreement for the requested change, from all listed authors and from the author to be removed or added.

Confidentiality
DHR Proceedings uses a single-blinded review process. Reviewer identities are not, and should not be, disclosed to the authors or other reviewers. In addition, authors should not contact those whom they presume to be reviewers of their manuscript.

Conflict of Interest and Financial Disclosure Policy
Authors. The corresponding Author is required to complete the ICMJE Form for Disclosure of Potential Conflicts of Interest statement on behalf of all authors. Authors should also include all financial support of the research and conflict of interest disclosures on the Cover letter of the manuscript.

Reviewers. Reviewers are required to disclose (on the reviewer score sheet) whether they have any financial or professional affiliations that may be perceived as a conflict of interest in reviewing a specific manuscript. Reviewers should decline to review any manuscript with which they have any conflict of interest issues regarding the topic, authors, or related affiliations that may hinder providing a fair and balanced review. If unsure, reviewers should contact the Editorial Office for clarification.

Editors and Journal Staff. Editors who make final decisions about manuscripts should recuse themselves from editorial decisions if they have conflicts of interest or relationships that pose potential conflicts related to articles under consideration. Other editorial staff members who participate in editorial decisions must provide editors with a current description of their financial interests or other conflicts (as they might relate to editorial judgments) and recuse themselves from any decisions in which a conflict of interest exists. Editorial staff must not use information gained through working with manuscripts for private gain as this will be considered serious misconduct and subject to sanctions.

Editorial Board members and journal staff are required to sign a conflict of interest and financial disclosure statement annually, which is kept confidential in the editorial office.

Role of the Funding Source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated as such in the acknowledgements section. Please see The Bethesda Statement on Open Access Publishing (http://legacy.earlham.edu/~peters/fos/bethesda.htm#definition)

Ethics in Publishing
Please refer to the document entitled “Responsible research publications: International standards for authors" that can be found here: https://publicationethics.org/files/International%20standards_authors_for%20website_11_Nov_2011.pdf International Standards

Human and Animal Research
All human studies must contain a statement within the Patients and Methods section indicating that the study has been approved by an institutional review board and that participants have signed written informed consent or that the institutional review board has waived the need for informed consent.

All research involving regulated animals (i.e. all live vertebrates and higher invertebrates) must be performed in accordance with relevant institutional and national guidelines and regulations. Approval of research involving regulated animals must be obtained from the relevant institutional review board or ethics committee prior to commencing the study. Confirmation of this approval is required upon submission of a manuscript to DHR Proceedings; authors must provide a statement identifying the full name of the ethics committee that approved the study. For most article types, this statement should appear in the Materials and Methods section. An example ethics statement: This study was carried out in accordance with the principles of the Basel Declaration and recommendations of [name of guidelines], [name of committee]. The protocol was approved by the [name of committee]. Should the study be exempt from ethics approval, authors need to clearly state the reasons in the declaration statement and in the manuscript. Studies involving privately owned animals should demonstrate the best practice veterinary care and confirm that informed consent has been granted by the owner/s, or the legal representative of the owner/s.

Registration of Clinical Trials
DHR Proceedings requires registration for all clinical trials submitted for publication. Trials that start enrollment after July 1, 2008, should be registered before starting patient enrollment. Clinical trials will need to be registered in 1 of the 5 registries accepted by the International Committee of Medical Journal Editors (ICJME) or in any of the primary registries that participate in the WHO International Clinical Trial Registry Platform. For additional information, please see http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html.

MANUSCRIPT PREPARATION

Authors should prepare manuscripts in accordance with the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals," developed by the ICMJE (www.icmje.org). Reports of randomized controlled trials should include the CONSORT flow diagram. For other reporting guidelines, please visit the Equator Network.

Manuscript

The manuscript should be typed in 12-point type and double-spaced throughout, and should be arranged as follows: (1) title page, (2) abstract, (3) alphabetical list of abbreviations used at least 3 times in the body of the manuscript (exclusive of abstract, figures, and tables) and their expansions, (4) text with appropriate headings and conclusion, (5) acknowledgments, (6) references, (7) figure legends, and (8) tables (with alphabetical list of all abbreviations and their expansions as a footnote). Manuscript pages should be numbered consecutively. The text portion of the manuscript should be saved using a word-processing program, such as a .doc or .rtf file format.

Tables should be created using your word processor's table function. Tables can be placed at the end of your manuscript document or saved as separate files.

Line art, including graphs and algorithms (flow charts), halftone and color images should be a minimum of 300 dpi. All images should be uploaded either as .jpg, .tiff or .eps formats.  We recommend using compression features when saving the images to preserve quality but reduce file size.  Figures should not be inserted or embedded into the manuscript document; rather, they should be saved and uploaded as separate files.

There are several freely available services over the web that provide conversion to images to the appropriate dpi.  We suggest to use https://pacev2.apexcovantage.com/

Title Page
Title: Formulate a title that reflects the content of the article. No more than 100 characters in length. Avoid questions and subtitles, and titles that tantalize but do not inform readers.
Authors: Include first names and middle initials, academic degrees, departmental affiliations and institutions, and current departmental and institutional affiliations for authors who have relocated since completion of the study.
Financial support and conflict of interest disclosure: List all financial and material support for the research and work described in the manuscript (eg, grant number and funding agency for the project, an individual author, or both). Each author must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. If there are no conflicts of interest, please provide a statement to that effect.
Corresponding author: Include name, address, and e-mail address of author to whom postpublication correspondence and reprint requests should be addressed.

Abstract
Abstracts should be no more than 250 words.

For Research Manuscripts:

Organize abstract in a structured format, with the following headings: Objective, Methods, Results, and Conclusion.
Ensure that information in each section of the abstract is in the corresponding section of the text.
Begin the "Objective" section of the Abstract with the word "To" and then state why you performed the study.

Objective should not exceed one sentence.In the Methods section of the Abstract and of the text, please provide the complete dates of the study, eg, January 1, 2000, through December 31, 2002.Please provide the Clinical Trials registration number at the end of the Abstract, if applicable.

Text

Express measurements in conventional units, giving conversion factor to SI units on first mention.

Give exact P values, even if they are non-significant. Style as P=.02 (italic letter, closed up, no initial zero). The lowest P value we report is P<.001. Round P values to 2 digits, except for the values in which the first 2 or 3 numbers after the decimal point are zeroes, then round to 3 or 4 digits, respectively. For P values that are less than .001 use P<.001.

Avoid specialized jargon and abbreviations; abbreviate a term only if it is used at least 3 times in text (exclusive of abstract, tables, and figures) and define at first mention.

Use generic names for drugs and equipment.

Do not use footnotes within the text.

For genetic nomenclature, please follow the recommendations of the Human Genome Organisation. Approved gene symbols, descriptions, and older aliases can be searched at genenames.org.

For gene mutations, please see the HGVS website (at hgvs.org [use the Recommendations Including Nomenclature Guidelines link] or http://www.hgvs.org/content/guidelines.

Acknowledgments
The corresponding author must provide assurance in writing that permission has been obtained from those acknowledged.

References

Authors are responsible for the accuracy and completeness of their references and for their complete and accurate citation in the text. Cite references, figures, and tables consecutively as they appear in the text; use sequential numbers in parenthesis for text citations.

Tables and Figures are considered part of text and so citations are numbered consecutively with those in text. Example: If Table 1 contains references, and the reference number in the text before citation of Table 1 is 5, a reference in Table 1 would become reference 6; the next reference cited in manuscript after table call-out would be cited as reference 7.

Cite personal communications (specify oral or written) and unpublished data parenthetically in the text and include date (do not list in references). The corresponding author must provide assurance in writing that permission has been obtained from those acknowledged.

In the reference list, include names and initials of all authors (if more than 6, list 3 followed by "et al"), the title, source (journal abbreviations should conform to those in Index Medicus), year, volume, issue, and expanded page ranges. For appropriate reference style, refer to the American Medical Association Manual of Style: A Guide for Authors and Editors, 10th ed. New York, NY; Oxford University Press; 2007:39-79.

We strongly encourage that authors use a reference management program to generate their bibliography such as End Note or Mendeley. Please use the Vancouver style when generating the bibliography.

Reference Style

Journals (Print)
1. Rainier S, Thomas D, Tokarz D, et al. Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch Neurol. 2004;61(7):1025-1029.

Journals (Online)
2. Ierano C, Thusky K, Peel T, Rajkhowa A, et al. Influences on surgical antimicrobial prophylaxis decision making by surgical craft groups, anaesthetists, pharmacists and nurses in public and private hospitals PLoS ONE 14(11): e0225011. https://doi.org/10.1371/journal.pone.0225011

 Chapter
3. Bithell TC. Hereditary coagulation disorders. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN, eds. Wintrobe's Clinical Hematology. Vol 2. 9th ed. Philadelphia, PA: Lea & Febiger; 1993:1422-1472.
Book
4. Guyton AC. Textbook of Medical Physiology. 8th ed. Philadelphia, PA: WB Saunders Co; 1991:255-262.
Web
5. Health Research and Educational Trust. Hospital Approaches to Interrupt the Cycle of Violence [Internet]. Chicago, IL; 2015. Available from: www.hope.org. Accessed Nov. 18, 2019.

Others

6. Subbarao M. Tough cases in carotid stenting [DVD]. Woodbury (CT): Cine-Med, Inc.; 2003. 1 DVD: sound, color, 4 3/4 in.

7. Stem cells in the brain [television broadcast]. Catalyst. Sydney: ABC; 2009 Jun 25.

Tables

Number tables consecutively (with Arabic numerals) in the order of their citation in the text.

Type all tabular material double-spaced; each table should be on a separate page.

Provide a title for each table; define all abbreviations used in each table in a footnote.

Superscripted lowercase letters (a-z) should be used for table footnotes.

Do not submit tables as images.

Illustrations

Cite all illustrations in the text and number them (with Arabic numerals) in the order of their appearance.

Provide a legend for each figure as part of the manuscript document. Include definitions of any abbreviations that appear on the figure, along with any permissions noted, and an appropriate citation.

For photomicrographs, specify stain and original magnification.

For any illustration with a recognizable patient, submit a release form signed by the patient.

Do not trim illustrations or assemble component parts.

We do not publish pie charts; three-dimensional figures are not acceptable; hatching should be avoided on bar graphs.

Line art, including graphs and algorithms (flow charts), should be created in PowerPoint.

Halftone and color images should be saved in in .jpg, .gif, or .tiff format at 300 dpi.

Illustrations borrowed from an external source require permission and credit line information from the publisher. See "Permissions" below.

Any figures submitted in color will appear in color online at no additional charge to the author.

Manipulation of Images
DHR Proceedings follows the Public Library of Science guidelines (https://journals.plos.org/plosone/s/figures) for the preparations of illustrations for a publication. No specific feature within an image may be enhanced, obscured, moved, removed, or introduced. Adjustments of brightness, contrast, or color balance are acceptable if and as long as they do not obscure or eliminate any information present in the original. Manipulating images for improved clarity is accepted, but manipulation for other purposes could be seen as scientific ethical abuse and will be dealt with accordingly.  We strongly encourage readers to see Rossner and Yamada, 2004. The Journal of Cell Biology, 166, 11-15. http://jcb.rupress.org/content/166/1/11.full)

Permissions

Use of previously published graphic and tabular material is strongly discouraged.

Authors are responsible for obtaining permission for reuse of material (illustrations, tables, or lengthy quotes) from other sources, including adaptations. The preferred and quickest method for obtaining permission is via the Copyright Clearance Center.

Permission letters from the copyright holder of the original source (along with complete bibliographic information) must be submitted with the manuscript. Failure to provide all appropriate permissions will delay publication or may necessitate the omission of a figure or table for which permission has not been received.

 Supplemental Materials
Publication of online supporting material is at the discretion of the Editorial Board. Online supplemental material will not be edited by the journal office, and it is the author's responsibility to ensure the accuracy of the data and the clarity of the format. Once accepted for publication, authors will not be provided an opportunity to review or modify online supplemental material.  Supplemental material may be requested by an Editor at his or/her discretion if deem essential for the completeness and accuracy of the publication.

Use the headings Supplemental Table or Supplemental Figure for your online supporting material and save and upload a PDF version of this material in the “Other” tab.

The following disclaimer is listed on the Journal's website: Supplemental material attached to journal articles has not been edited, and the authors take responsibility for the accuracy of all data.

Authors are responsible for ensuring the following:

Data (including percentages) are accurate and consistent with those cited in the manuscript.

Borrowed material should not be included as supplemental material.

Supplemental figures and tables meet the same formatting specifications as those for the print journal. For example, three-dimensional figures are not acceptable, hatching should be avoided on bar graphs, and pie charts are not acceptable.

All online supplemental material is correctly called out in the body of the manuscript in the appropriate location (eg, Supplemental Table 1, Supplemental Figure 1).

References in supplemental material should be numbered consecutively beginning with 1.

A title for each table and a legend for each figure are provided and all abbreviations are expanded in the table footnote or figure legend.

Table footnotes should be superscripted lowercase letters (a-z).

 

MANUSCRIPT CATEGORIES
Guidelines for the most frequent types of articles submitted to the journal are summarized below. Specific limits for word count, references, tables, and figures are provided in table format for quick reference. Authors are required to include the word count of the text, and the number of references, tables, and figures, on the Title page of the manuscript. Word count includes abstract but not the tittle page, references or acknowledgements.

Article Type	Abstract	Word Count	Max. References	Total number of Fig./Tables	Other
Commentaries	N/A	2000	25	3	--
Brief Reports	Unstructured	2000	25	3	--
Research Manuscripts	Structured	5000	75	10	--
Case Studies	Unstructured	3000	50	4	Limit 5 authors
Editorials	N/A	1200	10	1	Limit 3 authors
Review articles:  Systematic reviews and Meta-Analysis	Structured	6000	125	8	PRISMA checklist and PRISMA flowchart

Commentary
Commentaries are intended to offer expert insights into important or controversial topics related to clinical medicine, medical economics, governmental policy, ethics, or related issues. When appropriate, the Editorial Board expects authors to acknowledge a limited amount of supporting or opposing literature. Priority is given to novel thought, clear and creative writing, and the relevance of the manuscript to the interests of DHR Proceedings' readers.

Brief Report
A Brief Report will typically address an early report or observation of relevance to clinical medicine or medical science. This category is not intended to present preliminary data on structured, ongoing research but instead is intended to present unanticipated or extremely novel observations that may encourage others to perform related research or reassess their clinical practice.

Research Manuscripts
These include original articles describing prospective clinical trials, laboratory research, retrospective clinical analyses, and related research. Manuscripts with original and novel findings, particularly related to the clinical care of patients or the practice of clinical care will be given priority for publication. In addition to peer review, Editors may send original manuscripts to undergo statistical review by a doctorate degree statistician.

 

Case Reports
Case reports must include an unstructured abstract. The number of references, tables, and figures should be appropriate for the overall length of the paper. In general, no more than 2 tables or 2 figures are necessary. To better select the highest-quality case reports, the following guidelines will be used:

Reports that show: (1) A first-of-its-kind, unexpected, or unusual observation of a disease process that is relevant to a meaningful number of patients, such as: a new disease or syndrome; a previously unknown or important manifestation of a common disease or a new understanding of the pathophysiology of a common disease. (2) A new or first observation of an important adverse effect of a commonly used drug. (3) New therapeutic activity of a new treatment, including drug and non-drug therapies.

Review Articles
These consist of a critical assessment of literature and existing data. Priority for publication is given to topics with relevance to the clinical care of patients, the advancement of medical science, or improvements in health care delivery and economics. Authors are strongly encouraged to describe within the abstract and manuscript text the methods used to focus their search of the literature (eg, PubMed, MEDLINE), the search terms used, and the date limitations of the search. Also, please indicate how studies were selected for inclusion in the review. Provide 3-5 article highlights. These points should emphasize why our audience should read your article, describe what is new or cutting edge, and how it is of interest to your colleagues. The manuscripts most competitive for publication will introduce novel ideas or refreshing speculative syntheses and will address topics of importance to large numbers of patients, evolving medical issues, or mechanistically important topics.

A systematic review is defined as a review that followed an explicit a priori inclusion and exclusion criteria and comprehensive database search. Systematic reviews require submission of the PRISMA checklist and the PRISMA flow chart depicting the process of study selection. These documents are required for submission but do not have to necessarily be published.

Reviews that do not fit the criteria of systematic reviews and meta-analyses do not require PRISMA checklist or figure and require only a non-structured abstract, along with the 3 to 5 article highlights

Editorials
Submission of Editorials is by invitation from, or prior arrangement with, the Editorial Board. Most Editorials will comment on other material (eg, an innovative original article) appearing in the same issue of the journal or on changes in journal activities or policies. "Freestanding" editorials that comment on other topics, such as major changes in clinical medicine or health care policy, not originally introduced within the pages of the DHR Proceedings, are also published. Final acceptance of any Editorial, even an invited Editorial, is at the discretion of the Editorial Board.

ACCEPTANCE
All accepted manuscripts are edited according to the American Medical Association Manual of Style: A Guide for Authors and Editors, 10th ed. New York, NY; Oxford University Press; 2007, and the corresponding author will receive an approval copy of the page proofs before publication.

REPRINTS
Journal corresponding authors will receive a free PDF of their own articles for personal use only. Paper reprints are not currently available.

Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Articles should make no assumptions about the beliefs or commitments of any reader, should contain nothing which might imply that one individual is superior to another on the grounds of race, sex, culture or any other characteristic, and should use inclusive language throughout. Authors should ensure that writing is free from bias, for instance by using 'he or she', 'his/her' instead of 'he' or 'his', and by making use of job titles that are free of stereotyping (e.g. 'chairperson' instead of 'chairman' and 'flight attendant' instead of 'stewardess').

VIDEOS
We have the capacity to link a video with your article on our website. Videos should have an educational, not commercial, purpose. Interviews, a presentation of the highlights of the article, and an illustration of a given procedure would all be appropriate subjects for videos. For information about using your published material, please see Author Rights & Responsibilities.

Videos are considered to be part of the article and should not have been previously "published" (posted on another journal's website) or permission must be obtained for reuse.

Files should be in .wmv or .avi format. Typically, they should be no larger than 10 MB and no longer than 5 minutes. Minimum dimensions for the video should be 320 pixels wide by 240 pixels deep. Please verify that videos are viewable in QuickTime or Windows MediaPlayer.

Videos should be uploaded at the time of submission with the manuscript files via The “Multimedia” Tab in the submission page.  If you experience difficulty uploading the file, please submit the video file separately offline to the Editorial Office at [email protected].

COPYRIGHT

All accepted articles will be copyedited for clarity and consistency followed by scheduling for publication. Authors will have the opportunity to review the copyedited manuscript and to make additional changes, in consultation with the managing editor. Authors are expected to respond promptly to all inquiries from the editorial office in order to avoid delays in the production schedule.

All DHR Proceedings articles are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.

Upon submission, author(s) grant DHR Proceedings an exclusive license to publish, including to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing DHR Proceedings as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.

CORRECTIONS AND RETRACTIONS
DHR Proceeding recognizes the value correcting errors in previously published articles. If it is necessary to communicate important, scientifically relevant errors or missing information, and compelling evidence can be shown that a major claim of the original article was incorrect, a Correction should be submitted detailing the reason(s) for and location(s) of the change(s) needed using the below template. Corrections can be submitted if a small portion of an otherwise reliable publication proves to be misleading, e.g. an error in a figure that does not alter conclusions OR an error in statistical data not altering conclusions OR mislabeled figures OR wrong slide of microscopy provided, or if the author / contributor list is incorrect when a deserving author has been omitted or somebody who does not meet authorship criteria has been included. The contribution to the field statement should be used to clearly state the reason for the Correction. Please note, a correction is not intended to replace the original manuscript.

The title of the submission should have the following format: "Corrigendum: Title of original article".

If the error was introduced during the publishing process, the Journal managing editor should be contacted directly at [email protected].